| Long name: |
Cy5, 5 Conjugated, GALNT13/GalNAc-T13 Polyclonal Antibody |
| Category: |
Conjugated Primary Antibodies |
| Conjugation: |
Cy5, 5, 5, Cy5 |
| Host Organism: |
Rabbit (Oryctolagus cuniculus) |
| Target Antigen: |
GALNT13/GalNAc-T13 |
| Specificity: |
This is a highly specific antibody against GALNT13/GalNAc-T13 |
| Modification: |
Unmodified |
| Modification site: |
None |
| Clonality: |
Polyclonal |
| Clone: |
Polyclonal antibody |
| Concentration: |
1ug per 1ul |
| Source: |
KLH conjugated synthetic peptide derived from human GALNT13/GalNAc-T13 |
| Gene ID number: |
114805 |
| Tested applications: |
IF(IHC-P) |
| Recommended dilutions: |
IF(IHC-P)(1:50-200) |
| Crossreactivity: |
Mouse, Rat, Human |
| Crossreactive species details: |
not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Antigen background: |
GalNAc-T13 (Polypeptide N-acetylgalactosaminyltransferase 13), GalNAc-T13 may be responsible for the synthesis of Tn antigen in neuronal cells, The N-terminal domain is involved in substrate binding and manganese coordination, With specific expression in the central nervous system, also known as UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 13, is a 556 amino acid protein that displays much stronger enzymatic activity than GalNAc-1 towards GalNAc transfer to mucin peptides such as Muc5a and Muc7, thereby initiating mucin-type O-linked glycosylation in the Golgi apparatus, which is a universal carcinoma marker on malignant cells, while the C-terminal domain is involved in UDP-Gal binding and catalytic reaction, The UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase (GalNAc-T) family of enzymes are substrate-specific proteins that catalyze the transfer of GalNAc (N-acetylgalactosamine) to serine and threonine residues onto various proteins |
| Purification method: |
This antibody was purified via Protein A |
| Storage conditions: |
50% glycerol and 0, Store refrigerated at 2 to 8 degrees Celcius for up to 1 year, 09% sodium azide, Keep the antibody in an aqueous buffered solution containing 1% BSA |
| Excitation Emission: |
675nm/694nm |
| Synonyms: |
KIAA1918 GalNAc-T13 |
| Properties: |
Cy5 antibodies are excited by the 650-nanometer wave of an argon laser and detected at a 670-nanometer captor, C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Conjugated Antibodies they should be stored frozen at - 24° |
| Conjugated: |
These antibodies are excite for emission at 678nm and detected at a 694 , nm wavelengths |
| Gene target: |
GALNT13/GalNAc-T13 Conjugated |
| Short name: |
Conjugated, GALNT13/GalNAc-T13 Antibody |
| Technique: |
antibodies against human proteins, antibodies for, antibody Conjugates, Antibody |
| Label: |
5, Cy5 |
| Alternative name: |
cyanine 5, 5 coupled, GALNT13/GalNAc-T13 (Antibody to) |
| Alternative technique: |
antibodies |
| Identity: |
23242 |
| Gene: |
GALNT13 |
More about : GALNT13 |
| Long gene name: |
polypeptide N-acetylgalactosaminyltransferase 13 |
| Synonyms gene name: |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 13 (GalNAc-T13) |
| Synonyms name: |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 13 polypeptide GalNAc transferase 13 |
| Locus: |
2q23, 1 , 3-q24 |
| Discovery year: |
2003-12-02 |
| GenBank acession: |
AB067505 |
| Entrez gene record: |
114805 |
| Pubmed identfication: |
11572484 12407114 |
| RefSeq identity: |
NM_052917 |
| Classification: |
Polypeptide N-acetylgalactosaminyltransferases |
| Havana BLAST/BLAT: |
OTTHUMG00000131917 |